Management of Dupuytren's disease - Clear advice for an elusive condition

Annals of the Royal College of Surgeons of England

Volumn 88, Issue 1, 2006, Pages 3-8

  Bayat, Ardeshir ^a,b   McGrouther, D A ^a  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

Assessment; Contracture; Diagnosis; Dupuytren's disease; Referral; Treatment

Indexed keywords

COLLAGENASE; CORTICOSTEROID; FLUOROURACIL;

AGING; CAUCASIAN; CLINICAL TRIAL; CONVALESCENCE; DIABETES MELLITUS; DISEASE COURSE; DUPUYTREN CONTRACTURE; FAMILY HISTORY; FIBROMATOSIS; FLEXION CONTRACTURE; FOOT DISEASE; GENDER; HAND DISEASE; HAND FUNCTION; HAND MALFORMATION; HUMAN; OCCUPATIONAL THERAPY; ONSET AGE; PENIS DISEASE; PHYSIOTHERAPY; POSTOPERATIVE CARE; REVIEW; RISK FACTOR; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TREATMENT PLANNING;

DUPUYTREN'S CONTRACTURE; FEMALE; HUMANS; MALE; RISK FACTORS;

EID: 30044436675     PISSN: 00358843     EISSN: None     Source Type: Journal    
DOI: 10.1308/003588406X83104     Document Type: Review

References (34)

1. Dupuytren BG. Permanent retraction of the fingers, produced by an affection of the palmar fascia. Lancet 1834; ii: 222-5.
2. Burge P. Genetics of Dupuytren's disease. Hand Clin 1999; 15: 63-72.
3. Gudmundsson KG, Arngrimsson R, Jonsson T. Eighteen year follow-up study of the clinical manifestations and progression of Dupuytren's disease. Scan J Rheumatol 2001; 30: 31-4.
4. Leclercq C. Results of surgical treatment. In: Tubiana et al. (eds) Dopuytren's disease, 1st edn. London: Martin Dunitz, 2000; 239-50.
5. Gudmundsson KG, Arngrimsson R, Sigfusson N, Bjornsson A, Jonsson T. Epidemiology of Dupuytren's disease: clinical, serological, and social assessment. The Reykjavik Study. J Clin Epidemiol 2000; 53: 291-6.
6. Sladicka MS, Benfanti P, Raab M, Becton J. Dupuytren's contracture in the black population: a case report and review of the literature. J Hand Surg Br 1996; 21: 898-9.
7. McFarlane RM, Botz FS, Cheung H. Epidemiology of surgical patients. In: McFarlane RM, McGrouther DA, Flint M. (eds) Dupuytren's Disease Biology and Treatment. Edinburgh: Churchill Livingstone, 1990; 201-13.
8. Ling RS. The genetic factor in Dupuytren's disease. J Bone Joint Surg Br 1963; 45: 709-18.
9. Elliot D. The early history of contracture of the palmar fascia. Part 1: The origin of the disease: the curse of the MacCrimmons: the hand of benediction: Cline's contracture. J Hand Surg Br 1988; 13: 246-53.
10. Mikkelsen OA. The prevalence of Dupuytren's disease in Norway. Acta Chir Scand 1972; 138: 695-700.
11. Wilbrand S, Ekbom A, Gerdin B. The sex ratio and rate of reoperation for Dupuytren's contracture in men and women. J Hand Surg Br 1999; 24: 456-9.
12. Ross DC. Epidemiology of Dupuytren's disease. Hand Clin 1999; 15: 53-65.
13. Yi IS, Johnson G, Moneim M. Etiology of Dupuytren's disease. Hand Clin 1999; 15: 43-52.
14. Attali P, Ink O, Pelletier G, Vernier C, Jean F, Moulton L et al. Dupuytren's contracture, alcohol consumption, and chronic liver disease. Arch Intern Med 1987; 147: 1065-7.
15. Noble J, Arafa M, Royle SG, McGeorge G, Crank S. The association between alcohol, hepatic pathology and Dupuytren's disease. J Hand Surg Br 1992; 17: 71-4.
16. Thurston AJ. Dupuytren's disease. J Bone Joint Surg Br 2003; 85: 469-77.
17. Burge CP. Dupuytren's disease. J Bone Joint Surg Br 2004; 86: 1088, author reply 1088-9.
18. Gudmundsson KG, Arngrimsson R, Sigfusson N, Jonsson T. Increased total mortality and cancer mortality in men with Dupuytren's disease: a 15-year follow-up study. J Clin Epidemiol 2002; 55: 5-10.
19. Mikkelsen OA, Hoyeraal HM, Sandvik L. Increased mortality in Dupuytren's disease. J Hand Surg Br 1999; 24: 515-8.
20. Luck J. Dupuytren's contracture. A new concept of the pathogenesis correlated with surgical management. J Bone Joint Surg Am 1959; 41: 635-64.
21. Sergovich FR, Botz JS, McFarlane RM. Nonrandom cytogenetic abnormalities in Dupuytren's disease. N Engl J Med 1983; 308: 162-3.
22. Wurster-Hill DH, Brown F, Park JP, Gibson SH, Cytogenetic studies in Dupuytren contracture. Am J Hum Genet 1988; 43: 285-92.
23. Hueston JT. Lessons in Dupuytren's disease. Ann Chir Main Memb Super 1992; 11: 349-54.
24. Leclercq C. Results of surgical treatment. In: Tubiana R, Mackin EJ, Hurst LC, Leclercq C, Badalamente MA. (eds) Dupuytren's Disease. Taylor & Francis, 2000; 239-265.
25. Abe Y, Rokkaku T, Ofuchi S, Tokunaga S, Takahashi K, Moriya H. An objective method to evaluate the risk of recurrence and extension of Dupuytren's disease. J Hand Surg Br 2004; 29: 427-30.
26. Sinha R, Cresswell TR, Mason R, Chakrabarti I. Functional benefit of Dupuytren's surgery. J Hand Surgery Br 2002; 27: 378-81.
27. Messina A, Messina J. The continuous elongation treatment by the TEC device for severe Dupuytren's contracture of the fingers. Plast Reconstr Surg 1993; 92: 84-90.
28. Ketchum LD, Donahue TK. The injection of nodules of Dupuytren's disease with triamcinolone acetonide. J Hand Surg Am 2000; 25: 1157-62.
29. Adamietz B, Keilholz L, Grunert J, Sauer R. Radiotherapy of early stage Dupuytren disease. Long-term results after a median follow-up period of 10 years. Strahlenther Onkol 2001; 177: 604-10.
30. Badalamente MA, Hurst LC, Hentz VR, Collagen as a clinical target: nonoperative treatment of Dupuytren's disease. J Hand Surg Am 2002; 27: 788-98.
31. Bulstrode NW, Bisson M, Jemec B, Pratt AL, McGrouther DA, Grobbelaar AO. A prospective randomised clinical trial of the intra-operative use of 5-fluorouracil on the outcome of Dupuytren's disease. J Hand Surg Br 2004; 29: 18-21.
32. Bayat A, Watson JS, Stanley JK, Ferguson MWJ, Ollier WE. Genetic susceptibility to Dupuytren disease: association of Zf9 transcription factor gene. Plast Reconstr Surg 2003; 111: 2133-9.
33. Bayat A, Walter J, Lambe H, Watson JS, Stanley JK, Marino M et al. Identification of a novel mitochondrial mutation in Dupuytren's disease using multiplex DHPLC. Plast Reconstr Surg 2005; 115: 134-41.
34. McGrouther DA. Dupuytren's disease. In: Green DP, Hotchkiss RN, Pederson WC, (eds) Green's Operative Hand Surgery, Vol 1., 5th edn. New York: Churchill Livingstone, 2005.